Moreover, since a recent study identified indacaterol, a chronic obstructive pulmonary disease (COPD) treatment, as an SRSF6 protein inhibitor [15], we targeted this protein with this molecule and studied the effect of its inhibition on cell migration. The gene discussed is SRSF6; the disease is chronic obstructive pulmonary disease.